Peptide medicines & new families.
Explore how defined peptide medicines work in specific clinical settings, from melanocortin signaling and amylin to GLP-2, local gut receptors and bone biology. Keep molecular identity, formulation, indications and measured outcomes together.
Guides in this topic
Peptide FundamentalsLanreotide vs Octreotide: Formulations and Trial Evidence
Compare lanreotide and octreotide by formulation, half-life and trial endpoint. PROMID and CLARINET tested each medicine against placebo, rather than against each other.
Updated 2026-11-05 ↗
Peptide FundamentalsPegcetacoplan: C3 Inhibition Across Different Clinical Contexts
Pegcetacoplan binds complement C3 and C3b, but that target description does not make its different clinical settings equivalent.
Updated 2026-10-29 ↗
Peptide FundamentalsPramlintide: Understanding Amylin Beyond the GLP-1 Headlines
Pramlintide is an amylin analogue with a product-specific role alongside mealtime insulin. Its evidence should not be read as a generic weight-loss-peptide comparison.
Updated 2026-10-29 ↗
Peptide FundamentalsSetmelanotide: MC4 Signaling and Specific Obesity Conditions
Setmelanotide is an MC4-receptor agonist with a clinical record tied to specified causes and contexts of obesity.
Updated 2026-10-29 ↗
Peptide FundamentalsTeduglutide and GLP-2: Evidence in Short Bowel Syndrome
Teduglutide is a GLP-2 analogue whose clinical record concerns short bowel syndrome with dependence on parenteral support.
Updated 2026-10-29 ↗
Peptide FundamentalsVosoritide: CNP Signaling, Growth Velocity and Achondroplasia
Vosoritide is a C-type natriuretic peptide analogue studied for achondroplasia. Its evidence concerns growth-plate biology and growth velocity in an eligible pediatric population, not a general height-enhancement claim.
Updated 2026-10-29 ↗Ziconotide: A Conopeptide with a Very Specific Clinical Role
Ziconotide is a conopeptide medicine with a highly specific pain-management setting and route. Its N-type calcium-channel binding helps explain the research rationale, but the product record also contains substantial safety restrictions.
Updated 2026-10-29 ↗